Professor Andrew Steer is Director of Infection, Immunity and Global Health, and Group Leader of the Tropical Diseases Research Group, at the Murdoch Children’s Research Institute. He is a paediatric infectious diseases physician at the Royal Children’s Hospital Melbourne and a Professorial Research Fellow at the University of Melbourne. Andrew is the Co-Chair of Melbourne Children’s Global Health. He is a Fellow of the Australian Academy of Health and Medical Sciences.
Andrew did the majority of his medical training at The Royal Children’s Hospital, Melbourne. Andrew moved to Suva, Fiji, in 2005 where he conducted research towards his PhD (University of Melbourne). Subsequently, he completed his subspecialty training in paediatric infectious diseases at British Columbia Children’s Hospital in Vancouver, Canada, before returning to Melbourne in 2010.
Andrew’s research focuses on tropical diseases, particularly scabies, Strep A and rheumatic heart disease. He is the Director of the World Scabies Program, recipient of the Macquarie 50th Anniversary Award, and Director of the World Health Organisation Collaborating Centre on Scabies Control. Andrew is Co-Director of the Australian Strep A Vaccine Initiative, Co-Chair of the Strep A Vaccine Global Consortium, and President of the Lancefield International Society for Streptococci and Streptococcal Diseases.
Andrew has won several awards including the inaugural Jian Zhou Medal awarded by the Australian Academy of Health and Medical Sciences in 2020, the Bailey K Ashford Medal awarded by the American Society of Tropical Medicine and Hygiene in 2020, and the Sir Gustav Nossal Medal for Global Health awarded by the Australian Academy of Science in 2024.
Professor Andrew Steer is Director of Infection, Immunity and Global Health, and Group Leader of the Tropical Diseases Research Group, at the Murdoch Children’s Research Institute. He is a paediatric infectious diseases physician at the Royal...
Professor Andrew Steer is Director of Infection, Immunity and Global Health, and Group Leader of the Tropical Diseases Research Group, at the Murdoch Children’s Research Institute. He is a paediatric infectious diseases physician at the Royal Children’s Hospital Melbourne and a Professorial Research Fellow at the University of Melbourne. Andrew is the Co-Chair of Melbourne Children’s Global Health. He is a Fellow of the Australian Academy of Health and Medical Sciences.
Andrew did the majority of his medical training at The Royal Children’s Hospital, Melbourne. Andrew moved to Suva, Fiji, in 2005 where he conducted research towards his PhD (University of Melbourne). Subsequently, he completed his subspecialty training in paediatric infectious diseases at British Columbia Children’s Hospital in Vancouver, Canada, before returning to Melbourne in 2010.
Andrew’s research focuses on tropical diseases, particularly scabies, Strep A and rheumatic heart disease. He is the Director of the World Scabies Program, recipient of the Macquarie 50th Anniversary Award, and Director of the World Health Organisation Collaborating Centre on Scabies Control. Andrew is Co-Director of the Australian Strep A Vaccine Initiative, Co-Chair of the Strep A Vaccine Global Consortium, and President of the Lancefield International Society for Streptococci and Streptococcal Diseases.
Andrew has won several awards including the inaugural Jian Zhou Medal awarded by the Australian Academy of Health and Medical Sciences in 2020, the Bailey K Ashford Medal awarded by the American Society of Tropical Medicine and Hygiene in 2020, and the Sir Gustav Nossal Medal for Global Health awarded by the Australian Academy of Science in 2024.
Top Publications
Oliver, J, Osowicki, J, Cordell, B, Hardy, M, Engelman, D, Steer, AC.
Incidence of acute rheumatic fever and rheumatic heart disease in Melbourne, Australia from 1937 to 2013..
J Paediatr Child Health
56(9)
:
1408 -1413
2020
view publication
Lake, SJ, Phelan, SL, Engelman, D, Sokana, O, Nasi, T, Boara, D, Gorae, C, Schuster, T, Grobler, AC, Osti, MH, et al.
Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)..
BMJ Open
10(8)
:
e037305
2020
view publication
Frost, HR, Davies, MR, Velusamy, S, Delforge, V, Erhart, A, Darboe, S, Steer, A, Walker, MJ, Beall, B, Botteaux, A, et al.
Updated emm-typing protocol for Streptococcus pyogenes..
Clin Microbiol Infect
26(7)
:
946.e5 -946.e8
2020
view publication
Heenan, RC, Parks, T, Bärnighausen, T, Kado, J, Bloom, DE, Steer, AC.
The cost-of-illness due to rheumatic heart disease: national estimates for Fiji..
Trans R Soc Trop Med Hyg
114(7)
:
483 -491
2020
view publication
Auckland, K, Mittal, B, Cairns, BJ, Garg, N, Kumar, S, Mentzer, AJ, Kado, J, Perman, ML, Steer, AC, Hill, AVS, et al.
The Human Leukocyte Antigen Locus and Rheumatic Heart Disease Susceptibility in South Asians and Europeans..
Sci Rep
10(1)
:
9004
2020
view publication